A Report from 2nd International Symposium

The 2nd WJTOG International Symposium on Lung Cancer Clinical Trial
6th - 8th,July, 2006
NARA CITY, JAPAN
NARA Prefectural New Public Hall

Thank you for your participate in our symposium!!

Thursday, July 6

10:00-16:00	Excursion to Horyuji-Temple
18:00-19:00	Keynote Address (Nikko Nara Hotel) Chairperson　Dr. Nagahiro Saijo　National Cancer Center Hospital East Speaker　Prof. Giorgio V. Scagliotti　University of Torino
19:00-21:00	Welcome Party　Nikko Nara Hotel

Friday, July 7

9:00-9:15	Opening Remark and Introduction WJTOG　Prof. Masahiro Fukuoka　Kinki University School of Medicine, Sakai Hospital
9:15	Session I　Molecular Targeted Therapy in Metastatic NSCLC I-1 Clinical trial of EGFR-TKI Chairpersons 　Dr. Rafael Rosell　Hospital Germans Trias I Pujol 　Prof. Yoichi Nakanishi　Kyushu University Graduate School of Medical Sciences
9:15-9:35	Title：CALGB Trials with Molecular Targeted Therapy Speaker Prof. Everett E. Vokes　University of Chicago
9:35-9:45	Title：Prospective and Retrospective Study of Gefitinib in WJTOG (WJTOG0203A&0403) Speaker Dr. Kenji Tamura　Kinki University School of Medicine, Nara Hospital
9:45-10:00	Title：Korean Clinical Trials with Molecular Targeted Therapy Speaker Dr. Jin Soo Lee　National Cancer Center Korea
10:00-10:15	Title：Elrotinib monotherapy for Advanced NSCLC in Korea Speaker Dr. Keunchil Park　Samsung Medical Center Korea
10:15-10:45	Discussion Discussant Dr. Ikuo Sekine　National Cancer Center Hospital Tokyo
10:45	I-2 Biomarker & Clinical Trial Chairpersons 　Prof. Giorgio V. Scagliotti　University of Torino 　Prof. Hirotoshi Akita　Hokkaido University Graduate School of Medicine
10:45-11:00	Title：Gefitinib and EGFR Mutations Speaker Dr. Tetsuya Mitsudomi　Aichi Cancer Center Hospital
11:00-11:20	Title：Biomarker & Clinical Trial Speaker Dr. Rafael Rosell　Hospital Germans Trias i Pujol
11:20-11:50	Discussant Prof. Kazuto Nishio　Kinki University School of Medicine
11:50	I-3 New Molecurar Targeted Agents for Lung Cancer Chairpersons 　Prof. Noriyuki Masuda　Kitasato University School of Medicine 　Prof. Everett E. Vokes　University of Chicago
11:50-12:20	Title：New Molecular Targeted Agents for Lung Cancer (including bevacizumab) Speaker Prof. David R. Gandara　University of California Davis Cancer Center
12:20-12:50	Discussant Dr. Tomohide Tamura　National Cancer Center Hospital Tokyo
12:50-13:50	Lunch
13:50-14:45	Educational Lecture Title：Current Topics of Pathology in Lung Cancer Speaker Dr. William D.Travis 　Memorial Sloan Kettering Cancer Center
14:45-15:00	Break
15:00	Section　Meeting1 1-1　BAC & BAC Feature Chairpersons 　Dr. William D. Travis　Memorial Sloan Kettering Cancer Center 　Dr. Hisao Asamura　National Cancer Center Hospital
15:00-15:20	Title：Pathological Concept of BAC Speaker Prof. Masayuki Noguchi　Tsukuba University School of Medicine
15:20-15:35	Title：Radiologic and Pathologic Correlations in Small Adenocarcinoma of The Lung Speaker Dr. Kenji Suzuki　National Cancer Center Hospital Tokyo
15:35-16:05	Discussion Discussant 　Dr. Riichiro Maruyama　Nippon Steel Yawata Memorial Hospital
16:05	1-2　Clinical Trials for BAC and BAC Feature Chairpersons 　Dr. Jin Soo Lee　National Cancer Center Korea 　　Dr. Minoru Takada　NHO Kinki Cest Medical Center
16:05-16:25	Title：Clinical Trials in Patients with Advanced BAC Speaker Prof. David R. Gandara　University of California Davis Cancer Center
16:25-16:50	Discussion Discussant 　Prof. Junya Fukuoka　Toyama University Hospital
15:00	Section Meeting 2 2-1　The role of PET for Clinical Trials Chairpersons 　Prof. Hak Choy 　University of Texas Southwestern Medical Center 　Prof. Kenji Eguchi　Tokai University School of Medicine
15:00-15:20	PET in Resectable NSCLC Title：Current position of PET on Resectable NSCLC Speaker Prof. Joe B. Putnam　Vanderbilt University Medical Center
15:20-15:50	Discussion Discussant 　Dr. Takashi Seto　National Kyushu Cancer Center
15:50	2-2　PET in Unresectable NSCLC
15:50-16:10	Title：PET in RTOG Clinical Trial for Stage III NSCLC Speaker Dr. William T. Sause　LDS Hospital
16:10-16:25	Title：Current Clinical Status of PET in Europe Speaker Prof. Giorgio V. Scagliotti 　University of Torino
16:25-16:50	Discussion Discussant 　Dr. Seiji Niho　National Cancer Center Hospital East
17:00-17:50	Japanese Lyrical Noh Drama
18:00-20:30	Garden party was cancelled due to rainy climate. "KAGAMIWARI" ceremony, breaking up Sake barrels, by guest speakers.

Administration

Dr. Kenji Tamura

Dr. Ji-ichiro Sasaki

Saturday, July 8

9:00	SessionII II-1　Chemo-radiotherapy for Locally Advanced NSCLC Chairperson 　Prof. Kazushige Hayakawa　Kitasato University School of Medicine 　Prof. Yasumasa Nishimura 　Kinki University School of Medicine II-1-1　Chemotherapy Regimen and Schedule
9:00-9:20	Title：Clinical Trials for Locally Advanced NSCLC in USA Speaker Dr. William T. Sause　LDS Hospital
9:20-9:35	Title：Japanese Trials Speaker Dr. Nobuyuki Yamamoto　Shizuoka Cancer Center
9:35-10:05	Discussion Discussant 　Prof. Katsuyuki Kiura　Okayama University Graduate School of Medicine and Dentistry
10:05	II-1-2　RT Technology: Dose and Schedule
10:05-10:20	Title：Dose and Schedule of RT in Locally Advanced NSCLC (WJTOG3305) Speaker Dr. Takuhito Tada　Osaka City University Medical School
10:20-10:40	Title：Current Status of RT Technology in USA Speaker and Discussant Prof. Hak Choy　University of Texas Southwestern Medical Center
10:40-11:00	Discussion
11:00	II-2　Molecular Targeted Therapy for Locally Advanced NSCLC Chairperson 　Dr. William T. Sause　LDS Hospital 　Prof. Satoshi Ishikura　National Cancer Center Hospital East II-2-1　EGFR-TKIs
11:00-11:20	Title：SWOG0023 Speaker Prof. David H. Gandara　University of California Davis Cancer Center
11:20-11:35	Title：JOCG Trials of Gefitinib in Combination with RT Speaker Dr. Yuichiro Ohe　National Cancer Center Hospital Tokyo
11:35-12:05	Discussion Discussant 　Dr. Isamu Okamoto　Kinki University School of Medicine
12:05	II-2-2　EGFR/VEGF Antibodies
12:05-12:25	Title：Clinical Trials of EGFR/VEGF Ab in Combination with RT Speaker Prof. Hak Choy　University of Texas Southwestern Medical Center
12:25-12:55	Discussion Discussant 　Dr. Kaoru Kubota　National Cancer Center Hospital East
12:55-14:00	Lunch
14:00	SessionIII　Peri-operative Chemotherapy in Early Stage NSCLC III-1　Clinical Imprecations of CALGB 9633 Chairperson 　Dr. Haruhiko Kondo　Shizuoka Cancer Center 　Prof. Joe B. Putnam 　Vanderbilt University Medical Center
14:00-14:15	Title：CALGB Trials in Early Stage NSCLC Speaker Prof. Everett E. Vokes　University of Chicago
14:15-14:25	Comment Dr. Haruhiko Fukuda　National Cancer Center Hospital Tokyo
14:25-14:50	Discussion Discussant 　Dr. Hideo Kunitoh　National Cancer Center Hospital Tokyo
14:50	III-2　Adjuvant Chemotherapy in Early Stage NSCLC Chairperson 　Dr. Nagahiro Saijo　National Cancer Center East 　Prof. Kohei Yokoi 　Nagoya University School of Medicine
14:50-15:10	Title：Current US Trials in Early Stage NSCLC Speaker Prof. Joe B. Putnam　Vanderbilt University Medical Center
15:10-15:30	Title：Current Status of Adjuvant Chemotherapy in Early Stage NSCLC in Europe Speaker Prof. Giorgio V. Scagliotti　University of Torino
15:30-15:45	Title：Japanese Adjuvant Trial in Early Stage NSCLC Speaker Dr. Hirohito Tada　Osaka City General Hospital
15:45-16:15	Discussion Discussant 　Dr. Masahiro Tsuboi　Tokyo Medical University
16:15	III-3　Preoperative Chemotherapy in Early Stage NSCLC Chairperson 　Dr. Yukito Ichinose　National Kyushu Cancer Center 　　Prof. David R. Gandara　University of California Davis Cancer Center
16:15-16:30	Title：A Randomized Phase III Trial of Preoperative Chemotherapy vs Chemoradiotherapy for Patients with Stage IIIA ,N2 Non-small Cell Lung Cancer. A Preliminary Report. Speaker Dr. Nobuyuki Katakami　Kobe City General Hospital
16:30-16:45	Title：NATCH Trial Speaker Dr. Rafael Rosell　Hospital Germans Trias i Pujol
16:45-17:15	Discussion Discussant 　Dr. Takayasu Kurata　Hyogo Medical Center for Adults
17:15-17:35	Summary and Closing Remarks WJTOG　Prof. Kazuhiko Nakagawa　Kinki University School of Medicine